Dr Navita Somaiah is a Clinician Scientist and Team Leader in the Division of Radiotherapy and Imaging at the ICR and an Honorary Consultant Clinical Oncologist in the Breast Unit at The Royal Marsden NHS Foundation Trust.
After completing her DPhil in radiation biology at the University of Oxford, she became the first recipient of an ICR Clinician Scientist Fellowship award. Her research focuses on biological optimisation of radiotherapy by improving tumour response whilst minimising normal tissue toxicity, for a truly personalised approach.
In addition, she is the chief investigator of the national Phase I/II KORTUC trial and the Phase I PIMO trial that are looking at innovative approaches to tackling tumour hypoxia and radiosensitisation. She is the translational lead for two neoadjuvant breast radiotherapy trials at RM/ICR aimed at defining the radiation-induced immune landscape in primary breast cancers for optimal radio-immunotherapy combinations.
Dr Somaiah is a member of the Cancer Research UK Convergence Science Centre, which brings together leading researchers in engineering, physical sciences, life sciences and medicine to develop innovative ways to address challenges in cancer.
Convergence Science Centre